KTRA   $281.75  1.01% Market Closed

Kintara Therapeutics Inc
Total Cash 4.91M
totalCashPerShare 0.088
EBITDA -8.40M
Total Debt 0.00
quickRatio 2.173
currentRatio 2.447
Total Revenue
debtToEquity
Revenue/Share
ROA -1.03759
ROE -3.70766
grossProfits
freeCashflow -4.18M
operatingCashflow -7.18M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 17.98M
forwardPE
floatShares 55.59M
sharesOutstanding 55.66M
sharesShort 5.43M
sharesShortPriorMonth 1.19M
dateShortInterest
sharesPercentSharesOut 0.10%
heldPercentInsiders 0.00%
heldPercentInstitutions 0.01%
Short Ratio help_outline 1.14%
shortPercentOfFloat 0.10%
impliedSharesOutstanding
bookValue -0.117
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon -8.50M
trailingEps -0.32%
forwardEps -0.38%
enterpriseToEbitda -2.14
lastDividendValue
lastDividendDate
currentQuarterEstimate 3Q 2023
institutionsCount 17
lastUpdated Oct. 16, 2024, 9:53 p.m.